Federal employees would pay less for prescriptions and get more pharmacy choices.
This bill would change how prescription drug benefits work for federal employees. It would require pharmacy benefit managers (PBMs) to pass on drug manufacturer rebates directly to patients at the pharmacy counter, lowering out-of-pocket costs. It would also stop PBMs from limiting which pharmacies federal employees can use or how pharmacies are paid.
Today, federal employees might pay the full co-pay or coinsurance for a drug, and pharmacy benefit managers (PBMs) may keep manufacturer rebates or apply them later. PBMs also have more flexibility in how they reimburse pharmacies and can sometimes direct patients to specific pharmacies. After this bill, federal employees would see their co-pays or coinsurance reduced at the pharmacy counter by the amount of any manufacturer rebate. PBMs would have strict rules on pharmacy reimbursement and would be banned from limiting pharmacy choice or imposing certain fees.
HR 6610 · 119th Congress · December 11, 2025 · AI Summary by gemini-2.5-flash · 9/10
Sign in to see your representatives' phone numbers
17 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.